Načítá se...

Multitargeted Low-Dose GLAD Combination Chemoprevention: A Novel and Promising Approach to Combat Colon Carcinogenesis

Preclinical studies have shown that gefitinib, licofelone, atorvastatin, and α-difluoromethylornithine (GLAD) are promising colon cancer chemopreventive agents. Because low-dose combination regimens can offer potential additive or synergistic effects without toxicity, GLAD combination was tested for...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mohammed, Altaf, Janakiram, Naveena B, Brewer, Misty, Vedala, Krishna, Steele, Vernon E, Rao, Chinthalapally V
Médium: Artigo
Jazyk:Inglês
Vydáno: Neoplasia Press Inc. 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3638351/
https://ncbi.nlm.nih.gov/pubmed/23633920
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!